Patel Gautam
- SEC CIK
- 0001738054
No open-market purchases or sales filed in the past year.
Current role at each company
- AMRX Amneal Pharmaceuticals, Inc.Directoras of Aug 12, 2026
- SPB Spectrum Brands Holdings, Inc.Directoras of Dec 16, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Patel Gautam as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AMRX Amneal Pharmaceuticals, Inc.
Director9 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2025 (view filing) | Jun 16 | 2 days | Patel GautamDirector | SSaleClass A Common Stock | −94.9K | $8.02 | −$761.1K | −5.6%1.61M after | 10b5-1 |
| Jun 12, 2025 (view filing) | Jun 10 | 2 days | Patel GautamDirector | SSaleClass A Common Stock | −56.4K | $8.02 | −$452.5K | −3.2%1.70M after | |
| May 6, 2025 (view filing) | May 2-5 | 4 days | Patel GautamDirector | SSaleClass A Common Stock | −8.67K | $8.00 | −$69.3K | −0.5%1.72M after | 2 lots |
| Apr 2, 2025 (view filing) | Apr 1 | 1 day | Patel GautamDirector | SSaleClass A Common Stock | −80.0K | $8.30 | −$664.0K | −4.4%1.73M after | |
| Mar 5, 2025 (view filing) | Mar 3 | 2 days | Patel GautamDirector | SSaleClass A Common Stock | −80.0K | $8.90 | −$712.0K | −4.2%1.81M after | |
| Feb 5, 2025 (view filing) | Feb 3 | 2 days | Patel GautamDirector | SSaleClass A Common Stock | −80.0K | $8.14 | −$651.2K | −4.1%1.89M after | |
| Jan 10, 2025 (view filing) | Jan 8 | 2 days | Patel GautamDirector | SSaleClass A Common Stock | −62.6K | $8.01 | −$501.3K | −3.1%1.97M after | 10b5-1 |
| Jan 6, 2025 (view filing) | Jan 2 | 4 days | Patel GautamDirector | SSaleClass A Common Stock | −17.4K | $8.01 | −$139.5K | −0.8%2.03M after | 10b5-1 |
| Dec 20, 2021 (view filing) | Dec 17 | 3 days | Patel GautamDirector | PPurchaseClass A Common Stock | +50.0K | $4.21 | +$210.5K | +23.9%258.8K after |